GP
CTSO icon

GLG Partners’s Cytosorbents Corp CTSO Stock Holding History

GLG Partners’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$156K Buy
+24,047
New +$153K 0.01% 390

Other funds holding CTSO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $302M AUM 117.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BRF
B. Riley Financial Los Angeles, California $434M AUM 751.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
PG
PEAK6 Group Chicago, Illinois $23.4B AUM 17.65% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

GLG Partners's CTSO Position: Q4 2017 in Review

GLG Partners opened a new position in Cytosorbents Corp (CTSO) in Q4 2017: 24,047 shares worth $156K. The stake represents 0.01% of the portfolio and ranks #390 among its holdings.

43 funds tracked by Wall St. Rank hold CTSO as of Q4 2017.

  • GLG Partners held 24,047 shares of Cytosorbents Corp worth $156K as of Q4 2017.
  • Cytosorbents Corp was a new GLG Partners position in Q4 2017.
  • Cytosorbents Corp made up 0.01% of GLG Partners's portfolio in Q4 2017, its #390 holding.
  • 43 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2017.

Based on GLG Partners's 13F filing for Q4 2017, filed 14 Feb 2018.